NEW YORK (GenomeWeb News) – The Center for Autism and Related Disorders and molecular diagnostics firm Lineagen today announced a partnership to offer the FirstStep genetic test to patients.

Lineagen's whole-genome genetic test for autism spectrum disorders will be integrated with pre- and post-genetic counseling services and personalized reporting and will be available to patients in CARD's Skills program. The program is designed to meet clinical guidelines recommending chromosomal microarray analysis as a first-line genetic test to evaluate individuals with ASD.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.

The US Supreme Court has declined to review a decision involving the use of "inadvertently shed" DNA in a police investigation and subsequent conviction.

A panel at the New York Times discusses anonymity and privacy of users of 23andMe's services when access to its database is offered for research.

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.